Health officials warn of new flu strain outbreak

Key Concepts

• Drifted Variant: A strain of influenza that has accumulated mutations from previous seasons, potentially leading to a mismatch with the current vaccine.
• Vaccine Mismatch: A situation where the influenza strains circulating in the community have mutated significantly from the strains included in the seasonal flu vaccine, reducing its effectiveness.
• Antiviral Therapy: Medications used to treat influenza, which are most effective when administered early, especially in high-risk individuals.
• High-Risk Individuals: Groups such as the very young, the very old, immunocompromised individuals, and pregnant women, who are more susceptible to severe outcomes from influenza.

New Flu Strain and Vaccine Effectiveness

Health experts are closely monitoring a new flu strain that has emerged and caused outbreaks in the United Kingdom and Canada. This strain first appeared over the summer, approximately four months after the current year's flu vaccine was formulated. The head of the UK's National Health Service has reported that flu cases are currently triple the number seen at this time last year.

It remains uncertain whether this new strain has reached the United States. The Centers for Disease Control and Prevention (CDC) has not released a detailed report on influenza since September due to the government shutdown.

Dr. Ames Adalja, a senior scholar at the Johns Hopkins Center for Health Security, explains that this new strain is what is termed a "drifted variant." This means it has accumulated some mutations from what was expected or dominant in the previous flu season. Influenza seasons are characterized by multiple different strains, and this particular strain has mutated away from those included in the vaccine. While the mutation is not a "huge jump," it is significant enough to raise concerns about a potential vaccine mismatch.

Regarding the effectiveness of the current flu vaccine against this new strain, Dr. Adalja states that it depends on what is being measured. The vaccine's effectiveness against severe disease and hospitalization is estimated to be in the range of 40% to 50%. Its effectiveness against infection might be considerably lower, potentially around 20%. However, the primary goal of flu vaccination, similar to COVID-19 vaccination, is to prevent hospitalizations. Therefore, even with a potential mismatch, the vaccine is expected to offer protection, particularly against severe disease in high-risk individuals.

When to Seek Medical Attention

Individuals experiencing flu-like symptoms should contact their doctor if they belong to any high-risk categories. These categories include the very young, the very old, immunocompromised individuals, and pregnant women. For these individuals, prompt diagnosis and initiation of antiviral therapy are crucial, as antiviral treatments can be life-saving.

Home tests for influenza are now available, which individuals can use to confirm infection before contacting their doctor for a prescription for antiviral medication.